Federal and State Regulatory Changes to Methadone Take-Home Doses: Impact of Sociostructural Factors
Authors:
- Janan P. WyattJWJanan P. Wyatt
- Leslie W. SuenLSLeslie W. Suen
- William H. CoeWCWilliam H. Coe
- Zoe M. AdamsZAZoe M. Adams
- Mona GandhiMGMona Gandhi
- Hannah M. BatchelorHBHannah M. Batchelor
- Stacy CastellanosSCStacy Castellanos
- Neena JoshiNJNeena Joshi
- Shannon SatterwhiteSSShannon Satterwhite
- Rafael Pérez-RodríguezRPRafael Pérez-Rodríguez
- Esther Rodríguez-GuerraEREsther Rodríguez-Guerra
- Carmen E. Albizu-GarciaCACarmen E. Albizu-Garcia
- 1 April 2022
- journal article
- editorial
- Published by American Public Health Association in American Journal of Public Health
- Vol. 112 (S2) , S143-S146
Abstract
American Journal of Public Health (AJPH) from the American Public Health Association (APHA) Federal and State Regulatory Changes to Methadone Take-Home Doses: Impact of Sociostructural Factors, an article from American Journal of Public Health, Vol 112 Issue S2Keywords
This publication has 7 references indexed in Scilit:
- Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reformsJournal of Substance Abuse Treatment, 2022
- Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19Journal of Substance Abuse Treatment, 2021
- The impact of COVID-19 on opioid treatment programs in the United StatesDrug and Alcohol Dependence, 2021
- Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19Journal of Substance Abuse Treatment, 2021
- Private Coverage of Methadone in Outpatient Treatment ProgramsPsychiatric Services, 2020
- Medications for Opioid Use Disorder Save Lives2019
- Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based CareJournal of Addictive Diseases, 2015